TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
1-Year Return 21.62%
This Quarter Return
+10.56%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.98B
AUM Growth
+$171M
Cap. Flow
+$118M
Cap. Flow %
5.98%
Top 10 Hldgs %
35.03%
Holding
220
New
18
Increased
34
Reduced
52
Closed
20

Sector Composition

1 Healthcare 94.16%
2 Technology 1.37%
3 Industrials 1.32%
4 Communication Services 1.26%
5 Consumer Discretionary 0.8%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AFMD
201
DELISTED
Affimed
AFMD
-148,315
Closed -$107K
ALLK
202
DELISTED
Allakos
ALLK
-8,693,687
Closed -$1.98M
ATRA icon
203
Atara Biotherapeutics
ATRA
$90.7M
-75,196
Closed -$447K
JBIO
204
Jade Biosciences, Inc. Common Stock
JBIO
$254M
-1,993
Closed -$175K
BLUE
205
DELISTED
bluebird bio
BLUE
-400,000
Closed -$1.95M
CAPR icon
206
Capricor Therapeutics
CAPR
$308M
-79,100
Closed -$751K
CRSP icon
207
CRISPR Therapeutics
CRSP
$4.99B
-266,500
Closed -$9.07M
ELEV
208
DELISTED
Elevation Oncology
ELEV
-4,760,000
Closed -$1.23M
KRON
209
DELISTED
Kronos Bio
KRON
-1,345,413
Closed -$1.11M
LXRX icon
210
Lexicon Pharmaceuticals
LXRX
$396M
-1,150,268
Closed -$530K
NXTC icon
211
NextCure
NXTC
$13M
-33,679
Closed -$194K
OTLK icon
212
Outlook Therapeutics
OTLK
$41.5M
-400,000
Closed -$488K
PHAT icon
213
Phathom Pharmaceuticals
PHAT
$875M
-1,200,000
Closed -$7.52M
QNCX icon
214
Quince Therapeutics
QNCX
$86.5M
-184,383
Closed -$245K
RVPH icon
215
Reviva Pharmaceuticals
RVPH
$29.9M
-510,329
Closed -$487K
SLRN
216
DELISTED
ACELYRIN
SLRN
-9,818,115
Closed -$24.3M
VIR icon
217
Vir Biotechnology
VIR
$732M
-500,000
Closed -$3.24M
GRAL
218
GRAIL, Inc. Common Stock
GRAL
$1.33B
-11,300
Closed -$289K
ONC
219
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
-37,000
Closed -$10.1M
ITCI
220
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-220,000
Closed -$29M